Improvement in Polymyalgia Rheumatica Associated With Improved Control of Diabetes Mellitus: A Case Series
Abstract
Improved Control of Diabetes Mellitus: A Case Series Background: Polymyalgia rheumatica, a chronic inflammatory condition affecting elderly persons, is characterized by severe pain and stiffness, occurring mostly in the shoulders, upper arms, and pelvic girdle. We frequently encounter patients with both polymyalgia rheumatica and type 2 diabetes mellitus, but the association between these 2 diseases remains to be clarified. Objective: To raise the possibility that some patients with polymyalgia rheumatica and type 2 diabetes mellitus can avoid glucocorticoid treatment. Case Report 1: We took care of a 68-year-old man with bilateral shoulder pain and morning stiffness. He had been using nonsteroidal anti-inflammatory drugs (NSAIDs) without effect for 6 weeks and had been receiving metformin and a dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus for 5 years. His laboratory findings were as follows: C-reactive protein (CRP) level, 62.9 mg/L (normal, <1.4 mg/L); hemogloLETTERS
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.